deCODE and Illumina Form Alliance to Develop and Commercialize DNA-based Diagnostics
Companies to initiate work on molecular diagnostics for the risk of heart attack, type 2 diabetes and breast cancer
17-May-2006 -
deCODE genetics and Illumina, Inc. announced the formation of a strategic alliance under which the companies plan to co-develop and commercialize DNA-based diagnostic tests in several major disease areas. The alliance will employ Illumina's platform for high-multiplex single-nucleotide ...
analytical services
biomarkers
breast cancer
+17